Carol Carter

Title: Carol Carter: Innovator in Diagnostic Testing for Borrelia Infection

Introduction

Carol Carter is a distinguished inventor based in Bulverde, Texas. She has made significant contributions to the field of diagnostic testing, particularly concerning infections caused by Borrelia species. With a total of 2 patents, her work has implications for public health and disease management.

Latest Patents

Carter's latest patents focus on diagnostic tests for Borrelia infections. One of her notable inventions addresses the Lyme disease-like illness associated with bites from hard ticks, specifically Amblyomma americanum. Through the use of polymerase chain reaction, she has identified distinct sequences of the flagellin and 16s rRNA genes from microorganisms in Texas and New Jersey. These sequences indicate the presence of a new Borrelia species, which is different from the known B. burgdorferi, the agent of Lyme disease. Her diagnostic tests provide methods for determining the presence of this new spirochete and for identifying past or present infections in both animal reservoirs and humans.

Career Highlights

Carter is affiliated with the University of Texas System, where she continues her research and development in the field of infectious diseases. Her work has garnered attention for its innovative approach to understanding and diagnosing tick-borne illnesses.

Collaborations

Carter collaborates with Alan G. Barbour, a fellow researcher in the field. Their combined expertise enhances the quality and impact of their research efforts.

Conclusion

Carol Carter's contributions to the field of diagnostic testing for Borrelia infections highlight her role as an innovative inventor. Her work not only advances scientific knowledge but also has the potential to improve health outcomes for those affected by tick-borne diseases.